Roche has obtained acceptance from the US FDA for its NDA submitted for giredestrant, an oral therapy, along with everolimus...
AngioDynamics has expanded indications across Europe for its NanoKnife System to include soft tissue ablation.The post AngioDynamics expands European indications...
Serina Therapeutics has enrolled the first patient in its Phase Ib registrational trial of SER-252 for advanced Parkinson’s disease (PD).The...
Syngene International has entered a strategic collaboration with VivaMed BioPharma to advance AI-derived repurposed therapeutic programmes.The post Syngene and VivaMed...
NG Biotech and Hardy Diagnostics have received the US FDA breakthrough device designation for two rapid diagnostic assays, NG-TEST Candida...
Novartis has reported that its pivotal Phase III RemIND trial, evaluating oral remibrutinib in CIndU, achieved primary endpoint.The post Novartis’...
MSD and Mayo Clinic have entered a R&D collaboration to use AI, advanced analytics, and clinical data in support of...
Portal Diabetes has received the US FDA breakthrough device designation for its implantable insulin pump system, known as the Portal...
Janux Therapeutics has dosed the first participant in a Phase I clinical trial of JANX011, a CD19-targeted bispecific candidate designed...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.